Carnival Corporation (NYSE:CCL) stock rose Monday after the cruise operator reported record fourth-quarter profit and cash flow.Following the results, Goldman Sachs analyst Lizzie Dove raised her price forecast to $34 from $31 and reiterated a Buy rating.Earnings SnapshotThe company reported adjusted EPS of 34 cents, which topped the consensus by 9 cents. Revenue hit a fourth-quarter record $6.33 billion, up $400 million, though just shy of the $6.37 billion estimate.Also Read: Stock Of The Day: Is The Carn ...

Rocket Lab Corp. (NASDAQ:RKLB) has transitioned from a promising space startup to a dominant aerospace powerhouse—and its stock reflects the growth. RKLB stock is climbing. See the chart and price action here. Last week, the company secured its largest-ever contract—an $816 million deal with the U.S. Space Development Agency.Heading into the end of 2025, Rocket Lab has concluded its most successful year to date, marked by a combination of operational perfection and massive contract wins that have sent the s ...

Investors with a lot of money to spend have taken a bullish stance on EchoStar (NASDAQ:SATS).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SATS, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner spotted ...

In the current market session, Amdocs Inc. (NASDAQ:DOX) share price is at $80.35, after a 0.16% decrease. Over the past month, the stock increased by 5.43%, but over the past year, it actually decreased by 7.26%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.Comparing Amdocs P/E Against Its PeersThe P/E ratio measures the current share price to the company's EPS. It is used by ...

Moviegoers are showing up again. Investors, not so much. Shares of AMC Entertainment Holdings Inc (NYSE:AMC) are down more than 50% year to date, trading around $1.75 — just off 52-week lows — even as the company posts its strongest pre-Christmas weekend since 2021. Attendance surged on the back of “Avatar: Fire and Ash,” with more than four million customers visiting AMC and ODEON locations globally.Track AMC stock here.The disconnect hasn't gone unnoticed.Read Also: AMC Entertainment Stock Hits A New All- ...

U.S. stocks settled higher on Friday, with the Nasdaq Composite gaining around 300 points during the session as investors continued to show optimism towards the AI theme and positioned into December’s “triple witching” session.The Dow Jones closed higher by around 183 points to 48,134.89 on Friday. The S&P 500 rose 0.88% to 6,834.50, while the Nasdaq Composite jumped 1.31% to 23,307.62 during Friday's session.Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all an ...

BitMine Immersion Technologies Inc (NYSE:BMNR) added 98,852 Ethereum (CRYPTO: ETH) in the past week as the stock trades around $31 on Monday, just $2 above a critical support level.BMNR Holdings Hit 4 Million ETHBitmine now owns 3.37% of ETH’s circulating supply, two-thirds of the way to Chairman Thomas Lee’s “Alchemy of 5%” target.The company crossed 4.066 million ETH after just 5.5 months of aggressive accumulation, cementing its position as the world’s largest Ethereum treasury. Total assets including $1 ...

CRISPR Therapeutics AG (NASDAQ:CRSP) on Monday provided updates on zugocaptagene geleucel (zugo-cel, formerly CTX112), its investigational allogeneic CAR T targeting CD19, in development for autoimmune disease and hematologic malignancies.Autoimmune DiseaseZugo-cel, targeting CD19, is in an ongoing Phase 1 basket trial in autoimmune rheumatologic diseases.Preliminary clinical data from the Phase 1 study have been encouraging, and zugo-cel has been well-tolerated to date.Also Read: CRISPR Therapeutics’ Inves ...

Conagra Brands Inc (NYSE:CAG) reported mixed results for the second quarter on Friday.The company reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 44 cents per share. The company reported quarterly sales of $2.979 billion which missed the analyst consensus estimate of $2.986 billion.Sean Connolly, president and chief executive officer of Conagra Brands, said, “While we continued to navigate a challenging consumer environment in the second quarter, I am pleased w ...

Conagra Brands Inc (NYSE:CAG) reported mixed results for the second quarter on Friday.The company reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 44 cents per share. The company reported quarterly sales of $2.979 billion which missed the analyst consensus estimate of $2.986 billion.Sean Connolly, president and chief executive officer of Conagra Brands, said, “While we continued to navigate a challenging consumer environment in the second quarter, I am pleased w ...